Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Omega Diagnostics ( (GB:CNSL) ).
Cambridge Nutritional Sciences announced that Carolyn Rand, their Non-Executive Chair, has purchased 97,500 ordinary shares in the company, which represents approximately 0.04% of the company’s issued share capital. This acquisition may reflect confidence in the company’s future prospects and could influence stakeholder perception positively, enhancing the company’s position and market confidence.
More about Omega Diagnostics
Cambridge Nutritional Sciences plc (CNS) is a specialist medical diagnostics company focused on industry-leading health and nutrition products.
YTD Price Performance: 25.45%
Average Trading Volume: 488,986
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £8.69M
See more insights into CNSL stock on TipRanks’ Stock Analysis page.
